DGMT StemCell supplies for E0787301 & E0221001
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Points of contact
-
- Joshua Holliday joshua.holliday@fda.hhs.gov
- tbd@fda.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services Food and Drug Administration is forecasting a new contract for DGMT StemCell supplies to support PHCE project E0787301 and NTP project E221001. The procurement is categorized under Biological Product Manufacturing (NAICS 325414) and is not set aside for any specific business type. The estimated solicitation release date is November 1, 2025, with an anticipated contract award date of January 1, 2026.
While specific award values and quantities are not detailed in the forecast, the contract involves medium supplies for scientific research projects. The primary point of contact is Joshua Holliday, who can be reached at joshua.holliday@fda.hhs.gov, representing the FDA's organizational procurement team. The contract appears to be a standard government procurement for biological product supplies, with the performance location likely to be within the FDA's research facilities.
Forecast text
This contract is for medium supplies to support PHCE project E0787301 & NTP project E221001
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast